Lymphotoxin alpha Beta and LIGHT cytokine systems
Lymphotoxin alpha Beta and LIGHT cytokine systems
批准号:
7745496
负责人:
Carl F Ware
金额:
$21.38万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-08-01 至 2010-07-31
关键词:
AddressAffectAgonistAntigen-Presenting CellsAntigensAreaAscaridilAutoimmune ProcessAutoimmunityB cell differentiationBindingCellsCessation of lifeCommunicable DiseasesCommunicationCytokine Network PathwayCytomegalovirusDendritic CellsDevelopmentDiseaseEnzymesExperimental ModelsFamilyFundingFunding MechanismsFutureGenesGoalsGrantHerpesviridaeHomeostasisHost DefenseHumanImmuneImmune ToleranceImmune responseImmune systemImmunityInflammationInflammatoryInterferon Type IInternationalIntestinesInvestigationLigandsLymphocyteLymphoidMediatingMembraneModelingMolecularMucosal ImmunityMusOrganOrthologous GenePathway interactionsPatientsPeripheralPhysiologyPositioning AttributeProcessProgress ReportsReceptor SignalingRegulationReportingResearchRoleSignal PathwaySignal TransductionSyndromeSystemT-Cell ActivationT-LymphocyteTumor Necrosis Factor ReceptorTumor Necrosis Factor-BetaTumor Necrosis Factor-alphaTumor Necrosis FactorsVariantViral PathogenesisWorkattenuationbasecytokineexpression cloningherpesvirus entry mediatorinsightintercellular communicationmembernovelprogramsreceptorresponsetrend
中文摘要
T细胞的活化和分化依赖于TCR的抗原参与和协同信号
英文摘要
T cell activation and differentiation is dependent on TCR engagement of antigen and cooperating signals
provided by several distinct receptor-ligand systems. The herpesvirus entry mediator (HVEM), a TNF
superfamily member, engages LIGHT initiating costimulatory signals to T cells, yet HVEM also engages B
and T lymphocyte attenuator (BTLA), an Ig superfamily member that provides an inhibitory signal to T cells.
Substantial progress indicates that HVEM acts as a molecular switch between positive and inhibitory
cosignaling in T cells. Moreover, the HVEM-BTLA system counter acts the closely related LTa(3-LT|3R
system, which together regulates the homeostasis and expansion of specific subsets of dendritic cells in
lymphoid organs. Thus understanding the regulatory mechanisms of this cytokine network should provide
new insight into controlling immune responses. We found that LIGHT in either its membrane or soluble
position modifies the binding of HVEM to BTLA, thus the mechanisms controlling the cellular
compartmentalization of LIGHT may influence inhibitory signaling by BTLA. We propose to examine how
various forms of LIGHT modulate the HVEM-BTLA interaction. Specifically how soluble ligands and
polymorphic variants of LIGHT modify activation of BTLA. In addition, polymorphic variants of human LIGHT
will be examined for their influence on LIGHT shedding and the enzyme involved in cleavage of membrane
LIGHT will be identified using an expression cloning strategy. We will explore whether analogous pathways
to HVEM-BTLA exist for other TNFR containing the conserved BTLA binding domain. HVEM-BTLA acts at a
postmitotic step to limit dendritic cell expansion. The attenuation of death receptor signaling will be examined
as one mechanism mediating the inhibitory affect of HVEM-BTLA on dendritic cell homeostasis using mouse
and human models. These plans will provide a mechanistic understanding of how LTap and LIGHT signals
are integrated to orchestrate intercellular communication between T lymphocytes and dendritic cells during
immune responses.
Lay summary: Our research identified an important set of molecules, termed cytokines, that control how
immune cells communicate with each other. We demonstrated that altering the activity of these molecules
changes the responses of cells. This research provides a new opportunity to modify the function of the
immune system in autoimmune and infectious diseases
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Overriding the Immune Evasion Tactics of Coronavirus
-
批准号:10237419
-
项目类别:
-
资助金额:$61.8万
-
财政年份:2020
-
负责人:Carl F Ware
-
依托单位:
Overriding the Immune Evasion Tactics of Coronavirus
-
批准号:10671613
-
项目类别:
-
资助金额:$60.16万
-
财政年份:2020
-
负责人:Carl F Ware
-
依托单位:
Overriding the Immune Evasion Tactics of Coronavirus
-
批准号:10188930
-
项目类别:
-
资助金额:$61.8万
-
财政年份:2020
-
负责人:Carl F Ware
-
依托单位:
Overriding the Immune Evasion Tactics of Coronavirus
-
批准号:10454292
-
项目类别:
-
资助金额:$60.16万
-
财政年份:2020
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA Pathway in Lymphoma
-
批准号:8700133
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2012
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA Pathway in Lymphoma
-
批准号:8534744
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2012
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA Pathway in Lymphoma
-
批准号:8370219
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2012
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA Pathway in Lymphoma
-
批准号:9081538
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2012
-
负责人:Carl F Ware
-
依托单位:
MODULATING LYMPHOTOXINS IN PRIMATES FOR VIRAL DEFENSES
-
批准号:8357268
-
项目类别:
-
资助金额:$19.14万
-
财政年份:2011
-
负责人:Carl F Ware
-
依托单位:
Human Lymphoid Tissue Inducers
-
批准号:8136779
-
项目类别:
-
资助金额:$17.19万
-
财政年份:2010
-
负责人:Carl F Ware
-
依托单位:
MODULATING LYMPHOTOXINS IN PRIMATES FOR VIRAL DEFENSES
-
批准号:8172541
-
项目类别:
-
资助金额:$15.21万
-
财政年份:2010
-
负责人:Carl F Ware
-
依托单位:
Human Lymphoid Tissue Inducers
-
批准号:7874791
-
项目类别:
-
资助金额:$6.62万
-
财政年份:2010
-
负责人:Carl F Ware
-
依托单位:
Human Lymphoid Tissue Inducers
-
批准号:8020148
-
项目类别:
-
资助金额:$28.36万
-
财政年份:2010
-
负责人:Carl F Ware
-
依托单位:
MODULATING LYMPHOTOXINS IN PRIMATES FOR VIRAL DEFENSES
-
批准号:7959029
-
项目类别:
-
资助金额:$14.66万
-
财政年份:2009
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA system in inflammation
-
批准号:8143923
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2007
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA system in Inflammation
-
批准号:8890072
-
项目类别:
-
资助金额:$48.0万
-
财政年份:2007
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA system in inflammation
-
批准号:7848859
-
项目类别:
-
资助金额:$10.63万
-
财政年份:2007
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA system in inflammation
-
批准号:7413616
-
项目类别:
-
资助金额:$46.55万
-
财政年份:2007
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA system in inflammation
-
批准号:7264400
-
项目类别:
-
资助金额:$47.45万
-
财政年份:2007
-
负责人:Carl F Ware
-
依托单位:
HVEM-BTLA system in Inflammation
-
批准号:8507113
-
项目类别:
-
资助金额:$47.35万
-
财政年份:2007
-
负责人:Carl F Ware
-
依托单位:
海外基金